Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in ARDX — Ardelyx, Inc.

CIK 1115418 BOSTON, MA
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,559,580
-$188,541 QoQ
Shares Held
305,800
+4.8% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 250 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 21% Shared 0% None 79%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. ARDX ranks #114 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in ARDX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,559,580 305,800
2026-03-31 $1,748,121 291,840
2025-12-31 $1,736,896 297,924
2025-09-30 $1,878,292 340,888
2025-06-30 $1,368,601 349,133
2025-03-31 $1,666,630 339,436
2024-12-31 $1,653,448 326,124
2024-09-30 $2,205,172 320,054
2024-06-30 $2,504,335 337,967
2024-03-31 $2,464,290 337,574
2023-12-31 $2,025,936 326,764
2023-09-30 $1,242,131 304,444
2023-06-30 $1,001,050 295,295
2022-03-31 $104,839 97,981
2021-12-31 $104,681 95,165
2021-09-30 $128,785 97,565
2021-06-30 $713,846 94,175
2021-03-31 $563,659 85,145
2020-12-31 $618,693 95,625
2020-09-30 $446,696 85,085
2020-06-30 $681,274 98,450
2020-03-31 $550,290 96,797